The newly approved extended-release single-ingredient pain drug Zohydro ER™ (Zogenix®) is expected to be available for sale beginning in March. Zohydro ( hydrocodone bitartrate) was approved for marketing by the U.S. Food and Drug Administration on Oct. 25, 2013. As a single-ingredient hydrocodone product, it will be controlled in Schedule II.  Several group s and legislators hav... Read More